Can the COVID-19 virus be detected in the smoke generated in minimally invasive surgery in patients with confirmed coronavirus infection?

Detection of the COVID-19 virus, SARS-CoV-2, in surgical smoke during Laparoscopic Surgery (CoV2_LapSurg): a pilot investigation

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN18077365

Enrollment

Registered

2020-07-02

Start date

2020-05-25

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 (SARS-CoV-2 infection) detection in minimally invasive surgery Respiratory COVID-19 (SARS-CoV-2 infection), minimally invasive surgery

Interventions

This is an observational trial. The study aims at analyzing with PCR the bioaerosol collected through the Biosampler (SKC Inc, AMS Analitica) in solution during 20 consecutive major laparoscopic surgi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of COVID-19 confirmed through positive RT-PCR test before surgery 2. Scheduled laparoscopic procedure at least 1.5 h duration with major vessels exposure 3. Aged 18 to 90 years

Exclusion criteria

Exclusion criteria: Patients not able to give their informed consent

Design outcomes

Primary

Measure	Time frame
Correct detection of the presence of SARS-CoV-2 virus particles collected in surgical smoke during laparoscopic surgery through highly efficient Biosamplers and RT-PCR test when compared to the presence of SARS-CoV-2 RNA detected in plasma using RT-PCR in the same cohort prior to the procedure	—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

Italy

Contacts

Public ContactRuggero Bollino

ruggero.bollino@ausl.re.it+39 (0)522 296451

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026